MFDS — authorised 12 September 2012
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Aubagio in South Korea
MFDS authorised Aubagio on 12 September 2012
Marketing authorisation
Aubagio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Aubagio approved in South Korea?
Yes. MFDS authorised it on 12 September 2012.
Who is the marketing authorisation holder for Aubagio in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.